Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Evidence- |
RCV000495383 | SCV000579100 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 2 | 2017-06-29 | reviewed by expert panel | curation | Synonymous substitution variant, with low bioinformatic likelihood to result in a splicing aberration (Splicing prior probability 0.02; http://priors.hci.utah.edu/PRIORS/). |
Gene |
RCV001703634 | SCV000520087 | likely benign | not provided | 2021-01-21 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000524979 | SCV000635567 | likely benign | Hereditary breast ovarian cancer syndrome | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000581004 | SCV000683867 | likely benign | Hereditary cancer-predisposing syndrome | 2015-04-25 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000417809 | SCV000695056 | likely benign | not specified | 2020-09-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000581004 | SCV001188650 | likely benign | Hereditary cancer-predisposing syndrome | 2015-12-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Sema4, |
RCV000581004 | SCV002531852 | likely benign | Hereditary cancer-predisposing syndrome | 2021-05-18 | criteria provided, single submitter | curation | |
All of Us Research Program, |
RCV004804999 | SCV004844397 | likely benign | BRCA2-related cancer predisposition | 2024-06-17 | criteria provided, single submitter | clinical testing |